Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Domenico Gabrielli

Showing results (171-180 of 288) with videos related to

Pageof 29
Sort By:
Giornale Italiano Di Cardiologia (2006)|August 27, 2025
[ANMCO Position paper: ANMCO States General 2024 - In the era of precision cardiology, a reflection on the balance between cost containment and innovation]Giovanna Geraci, Attilio Iacovoni, Fabiana Lucà, et al.
JACC. Advances|October 29, 2025
Identifying Cardiogenic Shock Sub-Phenotypes with Machine Learning: A Multicenter Study Combining Clinical and Echocardiographic DataNicolò Ghionzoli, Andrea Stefanini, Geza Halasz, et al.
Giornale Italiano Di Cardiologia (2006)|September 27, 2021
[ANMCO Position paper: Cardio-oncology in the COVID-19 era]Irma Bisceglia, Domenico Gabrielli, Maria Laura Canale, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|August 30, 2021
ANMCO POSITION PAPER: cardio-oncology in the COVID era (CO and CO)Irma Bisceglia, Domenico Gabrielli, Maria Laura Canale, et al.
Journal of Cardiovascular Pharmacology|September 26, 2025
Time to Combinatorial Regimens: SGLT2i and PCSK9i in High-Risk Cardio-Oncology PatientsVincenzo Quagliariello, Massimiliano Berretta, Irma Bisceglia, et al.
Frontiers in Cardiovascular Medicine|December 12, 2022
Women at heart: Introducing gender cardio-oncologyMaria Laura Canale, Irma Bisceglia, Giuseppina Gallucci, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|April 16, 2024
ANMCO POSITION PAPER: The cardiological clinical activities in the transition phase of the COVID-19 pandemicSerafina Valente, Furio Colivicchi, Maura Giuseppina Francese, et al.
Giornale Italiano Di Cardiologia (2006)|July 1, 2023
[ANMCO Position paper in collaboration with ITACARE-P: Anti-ischemic treatment in patients with chronic coronary syndrome]Carmine Riccio, Gian Francesco Mureddu, Stefania Angela Di Fusco, et al.
International Journal of Molecular Sciences|May 4, 2026
SGLT2 Inhibitor Dapagliflozin Attenuates Cardiomyocyte Injury and Inflammation Induced by PI3Kα-Selective Inhibitor Alpelisib and Fulvestrant Under HyperglycemiaVincenzo Quagliariello, Massimiliano Berretta, Matteo Barbato, et al.
Giornale Italiano Di Cardiologia (2006)|May 28, 2025
[Heart, sport, and genetic testing]Stefania Angela Di Fusco, Silvia Castelletti, Cristina Chimenti, et al.
Pageof 29

Showing results (171-180 of 288) with videos related to

Sort By:
Pageof 29
Giornale Italiano Di Cardiologia (2006)|August 27, 2025
[ANMCO Position paper: ANMCO States General 2024 - In the era of precision cardiology, a reflection on the balance between cost containment and innovation]Giovanna Geraci, Attilio Iacovoni, Fabiana Lucà, et al.
JACC. Advances|October 29, 2025
Identifying Cardiogenic Shock Sub-Phenotypes with Machine Learning: A Multicenter Study Combining Clinical and Echocardiographic DataNicolò Ghionzoli, Andrea Stefanini, Geza Halasz, et al.
Giornale Italiano Di Cardiologia (2006)|September 27, 2021
[ANMCO Position paper: Cardio-oncology in the COVID-19 era]Irma Bisceglia, Domenico Gabrielli, Maria Laura Canale, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|August 30, 2021
ANMCO POSITION PAPER: cardio-oncology in the COVID era (CO and CO)Irma Bisceglia, Domenico Gabrielli, Maria Laura Canale, et al.
Journal of Cardiovascular Pharmacology|September 26, 2025
Time to Combinatorial Regimens: SGLT2i and PCSK9i in High-Risk Cardio-Oncology PatientsVincenzo Quagliariello, Massimiliano Berretta, Irma Bisceglia, et al.
Frontiers in Cardiovascular Medicine|December 12, 2022
Women at heart: Introducing gender cardio-oncologyMaria Laura Canale, Irma Bisceglia, Giuseppina Gallucci, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|April 16, 2024
ANMCO POSITION PAPER: The cardiological clinical activities in the transition phase of the COVID-19 pandemicSerafina Valente, Furio Colivicchi, Maura Giuseppina Francese, et al.
Giornale Italiano Di Cardiologia (2006)|July 1, 2023
[ANMCO Position paper in collaboration with ITACARE-P: Anti-ischemic treatment in patients with chronic coronary syndrome]Carmine Riccio, Gian Francesco Mureddu, Stefania Angela Di Fusco, et al.
International Journal of Molecular Sciences|May 4, 2026
SGLT2 Inhibitor Dapagliflozin Attenuates Cardiomyocyte Injury and Inflammation Induced by PI3Kα-Selective Inhibitor Alpelisib and Fulvestrant Under HyperglycemiaVincenzo Quagliariello, Massimiliano Berretta, Matteo Barbato, et al.
Giornale Italiano Di Cardiologia (2006)|May 28, 2025
[Heart, sport, and genetic testing]Stefania Angela Di Fusco, Silvia Castelletti, Cristina Chimenti, et al.
Pageof 29